Virocell, Inc.

At Virocell, we are committed to the development of new antiviral therapeutics to be used in the treatment of infectious diseases, as well as in certain types of cancers. An independent study conducted by FIND/SVP estimated the U.S. market for antiviral therapeutics and vaccines at more than 2 billion dollars U.S. (manufacturer's level) in 1995. The herpes virus market alone was valued at more than 600 million dollars U.S. with an estimated growth rate of more than 12% over the next five years.

Activity:

- Research & Development

Product / Technology type(s) covered:

- Pharmaceuticals / Therapeutics

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: